Cancer Stories
Didn't see your exact story?
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
A 67-year-old woman had a 2.7 cm mass detected at the 12 o’clock position of the left breast. Biopsy showed grade 2 invasive ductal carcinoma that was ER-positive, PR-positive, and HER2-negative.
She underwent left lumpectomy with placement of a BioZorb marker. Sentinel lymph nodes were negative for malignancy, and she completed postoperative radiation. Mammographic surveillance was then performed every six months.
Three and a half years after surgery, imaging showed a new asymmetry at the 12 o’clock position, along the lower edge of the resorbing BioZorb device. The location near the treated tumor bed made it important to distinguish a benign postoperative change from local recurrence.
Stereotactic biopsy showed fat necrosis with adjacent fibrosis and scar tissue. The pathology was considered concordant with the mammographic finding, and a six-month post-biopsy mammogram was recommended. The case illustrates how resorption of a BioZorb marker and healing around a lumpectomy site can create evolving findings that require continued imaging follow-up.
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer